Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 6
2003 4
2004 3
2005 3
2006 3
2007 3
2008 3
2009 5
2010 9
2011 5
2012 6
2013 1
2014 2
2016 1
2017 1
2021 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

47 results

Results by year

Filters applied: . Clear all
Page 1
[Drug-induced rhabdomyolysis].
Ueda S. Ueda S. Nihon Rinsho. 2007 Oct 28;65 Suppl 8:567-71. Nihon Rinsho. 2007. PMID: 18072348 Review. Japanese. No abstract available.
[Rhabdomyolysis].
Ueda S. Ueda S. Nihon Rinsho. 2012 Aug;70 Suppl 6:676-80. Nihon Rinsho. 2012. PMID: 23156596 Japanese. No abstract available.
Interactions of human organic anion transporters with aristolochic acids.
Babu E, Takeda M, Nishida R, Noshiro-Kofuji R, Yoshida M, Ueda S, Fukutomi T, Anzai N, Endou H. Babu E, et al. Among authors: ueda s. J Pharmacol Sci. 2010;113(2):192-6. doi: 10.1254/jphs.09339sc. Epub 2010 May 28. J Pharmacol Sci. 2010. PMID: 20508390 Free article.
Halofuginone prevents extracellular matrix deposition in diabetic nephropathy.
Sato S, Kawamura H, Takemoto M, Maezawa Y, Fujimoto M, Shimoyama T, Koshizaka M, Tsurutani Y, Watanabe A, Ueda S, Halevi K, Saito Y, Yokote K. Sato S, et al. Among authors: ueda s. Biochem Biophys Res Commun. 2009 Feb 6;379(2):411-6. doi: 10.1016/j.bbrc.2008.12.088. Epub 2008 Dec 27. Biochem Biophys Res Commun. 2009. PMID: 19114027
Patients' attitudes towards generic drug substitution in Japan.
Kobayashi E, Karigome H, Sakurada T, Satoh N, Ueda S. Kobayashi E, et al. Among authors: ueda s. Health Policy. 2011 Jan;99(1):60-5. doi: 10.1016/j.healthpol.2010.07.006. Epub 2010 Aug 4. Health Policy. 2011. PMID: 20685003
Acute nephrotoxicity of aristolochic acids in mice.
Sato N, Takahashi D, Chen SM, Tsuchiya R, Mukoyama T, Yamagata S, Ogawa M, Yoshida M, Kondo S, Satoh N, Ueda S. Sato N, et al. Among authors: ueda s. J Pharm Pharmacol. 2004 Feb;56(2):221-9. doi: 10.1211/0022357023051. J Pharm Pharmacol. 2004. PMID: 15005881
Acrolein, IL-6 and CRP as markers of silent brain infarction.
Yoshida M, Tomitori H, Machi Y, Katagiri D, Ueda S, Horiguchi K, Kobayashi E, Saeki N, Nishimura K, Ishii I, Kashiwagi K, Igarashi K. Yoshida M, et al. Among authors: ueda s. Atherosclerosis. 2009 Apr;203(2):557-62. doi: 10.1016/j.atherosclerosis.2008.07.022. Epub 2008 Jul 26. Atherosclerosis. 2009. PMID: 18757054
Selective toxicity of aristolochic acids I and II.
Shibutani S, Dong H, Suzuki N, Ueda S, Miller F, Grollman AP. Shibutani S, et al. Among authors: ueda s. Drug Metab Dispos. 2007 Jul;35(7):1217-22. doi: 10.1124/dmd.107.014688. Epub 2007 Mar 28. Drug Metab Dispos. 2007. PMID: 17392392
47 results